29 March 2018 - Health and Human Services Secretary Alex Azar is tapping a former CVS Caremark executive to lead the agency’s efforts to lower drug prices.
According to HHS, Daniel Best will be Azar’s senior adviser for drug pricing reform. Best was most recently a vice president of industry relations for CVS’s Medicare Part D business. This included the company’s prescription drug plans, Medicare Part D plans and other clients.
In a statement, Azar said Best will lead the agency’s initiatives aimed at lowering drug prices — a top priority for the Trump administration.